New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareChonluten vs Kisspeptin-10

Chonluten vs Kisspeptin-10

Side-by-side comparison of key properties, dosing, and research.

Anti-Aging & Longevity
Chonluten
Sexual Health & LibidoAnti-Aging & Longevity
Kisspeptin-10
Summary
Chonluten is a tripeptide bioregulator (Glu-Asp-Leu) developed by Professor Vladimir Khavinson, tissue-specific to the bronchi and lungs. While related to Bronchogen (a tetrapeptide), Chonluten is a shorter tripeptide sequence. It supports bronchial mucosal cell function, promotes respiratory epithelial regeneration, and is used in protocols for COPD, chronic bronchitis, and pulmonary anti-aging.
Kisspeptin-10 is the biologically active C-terminal decapeptide of kisspeptin, an endogenous regulator of the reproductive axis. It acts upstream of GnRH to potently stimulate LH and testosterone release, and plays a key role in sexual arousal and libido.
Half-Life
Short (minutes for the peptide); sustained gene-regulatory effects
~4 minutes (rapidly degraded); longer-acting analogs like TAK-448 are in development
Admin Route
SubQ, Oral
SubQ, IV
Research
Typical Dose
10 mg per day
50–500 mcg
Frequency
Daily for 10–30 days
Once daily to every other day
Key Benefits
  • Supports bronchial mucosal regeneration and repair
  • May improve mucociliary clearance in chronic respiratory conditions
  • Anti-inflammatory effects on bronchial epithelium
  • Pulmonary anti-aging and tissue preservation
  • Supports lung function in COPD and chronic bronchitis
  • Well tolerated in combination with other Khavinson bioregulators
  • Short tripeptide with efficient cellular penetration
  • Potently stimulates LH and testosterone
  • Enhances sexual arousal and libido
  • Activates HPG axis — upstream of GnRH
  • May improve fertility in hypogonadotropic hypogonadism
  • Increases brain activation in sexual attraction circuits
  • May restore LH pulsatility in suppressed HPG axis
Side Effects
  • Generally well tolerated
  • Mild injection site reactions possible
  • No significant adverse pulmonary events reported
  • Injection site reactions
  • Temporary nausea
  • Flushing
  • Elevated LH/testosterone (intended effect)
  • +1 more
Stacks With